Thomas Wanko
Internal Medicine · Columbus, OHNPI 1407854144
Payments from drug & device makers
Across 251 payments — averaging $13.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$573
- AbbVie$326
- Nevro Corp.$311
- AstraZeneca$266
- Merck$238
- Amgen$221
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,38499%
- Education$421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 59 | $573 |
| AbbVie(2 entities) | 29 | $326 |
| Nevro Corp. | 8 | $311 |
| AstraZeneca | 19 | $266 |
| Merck | 20 | $238 |
| Amgen | 18 | $221 |
| Novartis | 14 | $160 |
| Lilly USA, LLC | 11 | $148 |
| GSK | 9 | $141 |
| Boehringer Ingelheim | 9 | $140 |
| Grifols USA, LLC | 8 | $121 |
| Pfizer | 6 | $112 |
| Amarin Pharma, Inc. | 6 | $105 |
| Sanofi-aventis U.S. LLC | 7 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $52 |
| Astellas Pharma US Inc | 3 | $50 |
| Actelion Pharmaceuticals US, Inc. | 3 | $49 |
| Johnson & Johnson | 2 | $44 |
| Sunovion Pharmaceuticals Inc. | 3 | $43 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| Jazz Pharmaceuticals Inc. | 2 | $27 |
| Pharming Healthcare, Inc. | 1 | $25 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Advanced Respiratory, Inc | 1 | $16 |
| Medtronic | 1 | $16 |
| Abbott | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Philips North America LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$102
How this compares
$3,425 in reported general payments places this provider in the 85th percentile of 4,428 internal medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 17 | $21,833 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $16,136 |
| EliquisApixaban | 19 | $15,574 |
| EntrestoSacubitril/Valsartan | 11 | $7,082 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,753 |
| Atorvastatin Calcium | 112 | $960 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $779 |
| Propranolol Hcl ErPropranolol Hcl | 14 | $503 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 16 | $468 |
| Pantoprazole Sodium | 28 | $316 |
| Esomeprazole Magnesium | 12 | $311 |
| Omeprazole | 21 | $308 |
| Allopurinol | 23 | $307 |
| Levothyroxine Sodium | 21 | $239 |
| Gabapentin | 26 | $203 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $140 | $21,83317 claims |
| GSKTrelegy Ellipta | $141 | $16,13624 claims |
| PfizerEliquis | $112 | $15,57419 claims |
| NovartisEntresto | $160 | $7,08211 claims |
| AstraZenecaSymbicort | $266 | $3,75312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,428 internal medicine providers in Ohio.
Other internal medicine in Columbus
- Raghu KolluriColumbus$933K
- Antoinette PragalosCincinnati$27.8M
- Steven FolkerthBeavercreek$9.1M
- Charles EgerCincinnati$8.7M
- Vadim KoshkinCleveland$6.1M
- Nizar DaboulMaumee$4.7M
- Douglas LoganCincinnati$4.7M
- Seref BornovaliLoveland$4.4M
- Yevgeniy BukhmanCanton$3.7M
- Leela VrishabhendraCincinnati$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.